Your session is about to expire
← Back to Search
Mindfulness Based Intervention for Chronic Pain
Study Summary
This trial will study how different treatments for chronic pain affect the brain and body, with the goal of finding better ways to manage the condition.
- Chronic Pain
- Neuropathic Pain
- Complex Regional Pain Syndrome
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any individuals who can currently join this clinical trial?
"Affirmative, clinicaltrials.gov has updated information that this medical trial is actively enrolling patients. It was initially posted on November 25th 2020 and most recently modified on March 8th 2022. The study seeks to recruit 160 individuals from a single site."
Does this research trial allow me to join in as a participant?
"This trial is enrolling 160 volunteers aged 18 to 60 that suffer from chronic pain. Additional stipulations include: a self-reported health status free of cold and flu symptoms; no infections within the prior fortnight, no known sickle cell disease; not more than 550 mL blood donations in preceding 8 weeks or 1 draw during the week leading up to collection day; weighing 110+ pounds."
What is the enrollment capacity of this research endeavor?
"Affirmative. The information on clinicaltrials.gov states that this clinical trial is still in search of participants, which was first advertised on November 25th 2020 and last updated March 8th 2022. A total of 160 patients are sought after from a single medical centre."
Is there an age restriction for participating in this scientific experiment?
"Qualified applicants for this medical trial need to be between 18 and 60 years old. Younger individuals are able to participate in 41 separate studies, while those over 65 can take part in 491 different trials."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger